Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15376 - 15400 of 15440 in total

Bioymifi

Bioymifi is a small molecule that acts as a tumor necrosis factor-related apoptosis-induced ligand (TRAIL) mimetic. Upon binding to the death receptor 5 (DR5) on cancer cells, bioymifi triggers apoptosis, possibly through a caspase-dependent pathway. Bioymifi is currently being investigated as an anti-tumor agent.[A257048,A257053]
Investigational

N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine

Experimental

5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one

Experimental

Ghavamiol

Experimental

1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE

Experimental

ING-1

ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational

KB002

KB002 is an engineered human IgG1k antibody engineered human. It is developed for the treatment of autoimmune diseases, initially rheumatoid arthritis.
Investigational

Amitifadine

Investigational

R450

R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
Investigational

Buflomedil

Experimental

1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE

Experimental

Cerlapirdine

Cerlapirdine has been investigated for the treatment of Alzheimer Disease.
Investigational

BMS-863233

BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Investigational

Dihydroquinidine barbiturate

Experimental

1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine

Experimental

Moperone

Experimental

Propiopromazine

Experimental
Vet approved

RG-7795

Investigational

FavId

FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational

Plinabulin

Investigational

2-Nitro-4-cresol

Experimental

ISIS 113715

ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant reductions in LDL-cholesterol.
Investigational

{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone

Experimental

Alamifovir

Alamifovir is an antiviral agent specific for HBV.
Investigational

IMIDAZOPYRIDAZIN 1

Experimental
Displaying drugs 15376 - 15400 of 15440 in total